Elia J. Celecoxib gets partial exoneration from FDA panels. Physician's First Watch 2018:5. [Ref.ID 102574]

Grosser T, Ricciotti E, Fitzgerald GA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 2017;38:733-48. [Ref.ID 101990]

Grosser T. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2017;376:1389-90. [Ref.ID 101526]

Felson DT. Safety of nonsteroidal antiinflammatory drugs.. N Engl J Med 2016;373:2595-6. [Ref.ID 101348]

Anónimo. Celecoxib safety revisited. The Medical Letter on Drug and Therapeutics Bulletin 2016;58:159. [Ref.ID 101041]

Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckeman B, Berger MF, Bao W, Lincoff AM, for the PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016;373:2519-29. [Ref.ID 101038]

Elmore JG, Nelson HD, Pepe MS, Longton GM, Tosteson ANA, Geller B, Onega T, Carney PA, Jackson SL, Allison KH, Weaver DL. Variability in pathologists' interpretations of individual breast biopsy slides: a population perspective. Ann Intern Med 2016;164:649-55. [Ref.ID 100080]

Lenzer J. Truly independent research?. BMJ 2008;337:602-6. [Ref.ID 83973]

Grimes D. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med 2008;149:273-5. [Ref.ID 83815]

Chan FKL, Wong VWS, Suen BY, Wu JCY, Ching JYL, Hung LCT, Hui AJ, Leung VK, Lee VWY, Lai LH, Wong GLH, Chow DKL, To KF, Leung W-K, Chiu PWY, Lee YT, Lau JYW, Chan HLY, Ng EKW, Sung JJY. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007;369:1621-6. [Ref.ID 80059]

Scheiman JM, Fendrick AM. Summing the risk of NSAID therapy. Lancet 2007;369:1580-1. [Ref.ID 80054]

Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42. [Ref.ID 79469]

Anónimo. New threat to Celebrex safety profile. Scrip 2006;3138:24. [Ref.ID 76308]

Anónimo. Celebrex CV safety in the balance with new study. Scrip 2005;3117:22. [Ref.ID 75777]